Make an impact.
Save lives.

It’s why we ride

This is Pelotonia. The expectation-defying, cancer-fighting grassroots community of tens of thousands of people rallying around One Goal.

Register

At Pelotonia, we’re driven by our mission: to engage, inspire, and challenge a community committed to change the world by accelerating innovative cancer research.

Pelotonia is a community that is passionate about Ending Cancer. Through annual cycling and event experiences, volunteerism, and year-round fundraising, we have raised more than $339 million for innovative cancer research. And we're not done yet.

pelotonia by
the numbers

$339M+

FUNDS RAISED FOR CANCER RESEARCH SINCE 2009

In 2025, the Pelotonia community raised $29,212,864 million for innovative cancer research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, bringing all-time funds raised to $339,074,826.

the pelotonia impact

100% of every participant-raised dollar goes directly to innovative cancer research.

Joe Apgar | CEO, Pelotonia

 Pelotonia was founded on the belief that, together, we will end cancer. As a community, we’ve made remarkable progress.”

2025 Number Reveal Video

Record-Breaking Community Fundraising

Community unites to celebrate $29.2 million record-breaking fundraising total, bringing all-time funds raised to $339 million for the OSUCCC – James. Watch the countdown video that revealed the total on stage at Night of Impact 2025!

Pelotonia News

Featured Stories

In the News

Pelotonia Breaks Fundraising Record with $29.2 Million in 2025
The 2025 total marks the highest single-year fundraising achievement in the Pelotonia community’s 17-year history.
Read More

Research Stories

Locally Developed Cancer Drug Moves to Clinical Trial
A powerful new cancer-fighting drug, developed entirely at The Ohio State University, is now entering its first human clinical trial, offering new hope for patients.
Read More

Research Stories

Ohio State Recruits Renowned Researcher in Immunology
Dr. Glen Barber builds on groundbreaking discovery that may lead to new treatments for cancer and inflammation.
Read More

Research Stories

Genetic Mutations Link Could Lead to New AML Treatment
Researchers have found a connection between two genetic mutations in a subtype of acute myeloid leukemia (AML) — a finding that could lead to new ways to treat this aggressive blood cancer.
Read More

Research Stories

OSUCCC – James CEO Commends Community's Devotion
W. Kimryn Rathmell, MD, PhD, marked her inaugural Ride Weekend with both a personal milestone and a vivid introduction to the vibrant, purpose-driven community fueling cancer research.
Read More

Funding Partners

Thanks to our generous funding partners

100% of every participant-raised dollar goes to innovative cancer research at the OSUCCC – James.